2013-10-07 08:10:00 CEST

2013-10-07 08:11:00 CEST


REGULATED INFORMATION

English
Revenio Group Oyj - Total number of voting rights and capital

Revenio Group Corporation : INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER



   Revenio Group Corporation Stock Exchange Release   7 October 2013, 09:10 hrs

   INCREASED NUMBER OF SHARES ENTERED INTO TRADE REGISTER

   4,125 new share subscriptions based on the company's 2007B stock options by
   the number of 1,400 and 2007C stock options by the number of 2,725 approved
   by the Board of Directors of Revenio Group Corporation on 20 September
   2013, have been entered into the trade register today. The share
   subscription price under 2007B option rights is 2.35 per share and under
   2007C option rights EUR 2.29 per share. The subscription period for 2007B
   options is from 1 November 2010 to 1 November 2014 and for 2007C options
   from 1 May 2012 to 1 May 2016.

   After these subscriptions, the number of Revenio Group Corporation's shares
   and votes will rise to 7,843,034. These increases were recorded in their
   entirety in the unrestricted shareholders' equity fund.

   Revenio Group Corporation has applied for the listing of its new shares on
   the
   NASDAQ OMX Helsinki in the same series as the company's existing shares.
   According to the current estimate, the new shares will be listed on 8
   October 2013.

   Revenio Group Corporation

   Olli-Pekka Salovaara

   President and CEO

   For further information, please contact:

   Olli-Pekka Salovaara, President & CEO, +358 (0)40 567 5520 (mobile)

   olli-pekka.salovaara@revenio.fi

   http://www.revenio.fi/

   DISTRIBUTION:

   NASDAQ OMX Helsinki

   Financial Supervisory Authority (FIN-FSA)

   Key media

   www.revenio.fi

   The Revenio Group in brief

   Revenio is a Finnish health tech group whose core business is tonometers.
   The
   Revenio Health Tech segment comprises the operations of Icare Finland Oy.
   The
   widely patented Icare product family is the current cornerstone of the
   Group's
   success. Revenio seeks vigorous growth in health technology, both
   organically
   and through acquisitions and mergers.

   The Revenio Group also includes other business operations, which are grouped
   under the Technology and Services segment. This segment's operations have a
   shared global market and represent the cutting edge of technology products
   and
   services in their industry. These businesses are extremely profitable in
   their
   industries and generate positive cash flow.

   In 2012, the Revenio Group's net sales totaled EUR 25.4 million, with its
   operating margin standing at 19.4 percent. The Revenio Group Corporation is
   listed on NASDAQ OMX Helsinki.

[HUG#1733495]